Feedback / Questions
lirentelimab subcutaneous (AK002 SC) - Allakos
http://clinicaltrials.gov/ct2/show/NCT05155085
Mar 8, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next